Showing results (1-10 of 399) with videos related to
Sort By:
Pageof 40
Methods in Cell Biology|February 14, 2022
Generation and functional characterization of CAR exosomesChuqi Wang, Wenyan Fu, Changhai Lei, et al.View (Beijing, China)|November 12, 2021
Therapeutic antibodies under development for SARS-CoV-2Zetong Ma, MengMei Zhu, Shuyi Zhang, et al.Nature Biomedical Engineering|June 6, 2022
Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapyWenyan Fu, Changhai Lei, Chuqi Wang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 20, 2025
T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 InfectionWenyan Fu, Wei Zhang, Zhongshuai You, et al.Journal of Experimental & Clinical Cancer Research : CR|September 27, 2022
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapyKewen Qian, Wenyan Fu, Tian Li, et al.Clinical Immunology (Orlando, Fla.)|April 22, 2019
Treatment of murine lupus with TIGIT-IgShuowu Liu, Lizhu Sun, Chuqi Wang, et al.Theranostics|July 13, 2023
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequencyWenyan Fu, Guangyao Li, Changhai Lei, et al.Nature Communications|April 26, 2020
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-IgChanghai Lei, Kewen Qian, Tian Li, et al.Frontiers in Immunology|April 12, 2021
TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal ToleranceWenyan Fu, Renfei Cai, Zetong Ma, et al.Frontiers in Immunology|August 9, 2021
CAR Macrophages for SARS-CoV-2 ImmunotherapyWenyan Fu, Changhai Lei, Zetong Ma, et al.Pageof 40